These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21323159)

  • 1. Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border.
    Maneeboonyang W; Lawpoolsri S; Puangsa-Art S; Yimsamran S; Thanyavanich N; Wuthisen P; Prommongkol S; Chaimongkul W; Rukmanee P; Rukmanee N; Chavez IF; Buchachart K; Krudsood S; Singhasivanon P
    Southeast Asian J Trop Med Public Health; 2011 Jan; 42(1):9-18. PubMed ID: 21323159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
    Takeuchi R; Lawpoolsri S; Imwong M; Kobayashi J; Kaewkungwal J; Pukrittayakamee S; Puangsa-art S; Thanyavanich N; Maneeboonyang W; Day NP; Singhasivanon P
    Malar J; 2010 Nov; 9():308. PubMed ID: 21040545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of therapeutic efficacy of chloroquine for vivax malaria in Thailand.
    Vijaykadga S; Rojanawatsirivej C; Congpoung K; Wilairatana P; Satimai W; Uaekowitchai C; Pumborplub B; Sittimongkol S; Pinyorattanachote A; Prigchoo P
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):566-9. PubMed ID: 15689067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India.
    Yadav RS; Ghosh SK
    J Parasitol; 2002 Oct; 88(5):1042-4. PubMed ID: 12435158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
    Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
    Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
    Walsh DS; Wilairatana P; Tang DB; Heppner DG; Brewer TG; Krudsood S; Silachamroon U; Phumratanaprapin W; Siriyanonda D; Looareesuwan S
    Clin Infect Dis; 2004 Oct; 39(8):1095-103. PubMed ID: 15486831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of primaquine standard dose (15 mg/day for 14 days) in the treatment of vivax malaria patients in Thailand.
    Buchachart K; Krudsood S; Singhasivanon P; Treeprasertsuk S; Phophak N; Srivilairit S; Chalermrut K; Rattanapong Y; Supeeranuntha L; Wilairatana P; Brittenham G; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):720-6. PubMed ID: 12041544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days.
    Carmona-Fonseca J; Maestre A
    Acta Trop; 2009 Nov; 112(2):188-92. PubMed ID: 19653988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria.
    Chu CS; Phyo AP; Turner C; Win HH; Poe NP; Yotyingaphiram W; Thinraow S; Wilairisak P; Raksapraidee R; Carrara VI; Paw MK; Wiladphaingern J; Proux S; Bancone G; Sriprawat K; Lee SJ; Jeeyapant A; Watson J; Tarning J; Imwong M; Nosten F; White NJ
    Clin Infect Dis; 2019 Apr; 68(8):1311-1319. PubMed ID: 30952158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroquine sensitivity of Plasmodium vivax in Thailand.
    Looareesuwan S; Wilairatana P; Krudsood S; Treeprasertsuk S; Singhasivanon P; Bussaratid V; Chokjindachai W; Viriyavejakul P; Chalermrut K; Walsh D S; White J
    Ann Trop Med Parasitol; 1999 Apr; 93(3):225-30. PubMed ID: 10562823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' adherence and clinical effectiveness of a 14-day course of primaquine when given with a 3-day chloroquine in patients with Plasmodium vivax at the Thai-Myanmar border.
    Cheoymang A; Ruenweerayut R; Muhamad P; Rungsihirunrat K; Na-Bangchang K
    Acta Trop; 2015 Dec; 152():151-156. PubMed ID: 26278026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand.
    Hamedi Y; Safa O; Zare S; Tan-ariya P; Kojima S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):570-4. PubMed ID: 15689068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical-parasitological response and in-vitro sensitivity of Plasmodium vivax to chloroquine and quinine on the western border of Thailand.
    Tasanor O; Ruengweerayut R; Sirichaisinthop J; Congpuong K; Wernsdorfer WH; Na-Bangchang K
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):410-8. PubMed ID: 16497347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of Plasmodium vivax to chloroquine in Laza City, Myanmar].
    Liang GL; Sun XD; Wang J; Zhang ZX
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Apr; 27(2):175-6. PubMed ID: 19856512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo sensitivity monitoring of chloroquine for the treatment of uncomplicated vivax malaria in four bordered provinces of Thailand during 2009-2010.
    Congpuon K; Satimai W; Sujariyakul A; Intanakom S; Harnpitakpong W; Pranuth Y; Cholpol S; Bualombai P
    J Vector Borne Dis; 2011 Dec; 48(4):190-6. PubMed ID: 22297279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
    Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
    Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine.
    Dao NV; Cuong BT; Ngoa ND; Thuy le TT; The ND; Duy DN; Dai B; Thanh NX; Chavchich M; Rieckmann KH; Edstein MD
    Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):534-9. PubMed ID: 17368694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on Plasmodium vivax relapse pattern in Kheda district, Gujarat.
    Srivastava HC; Sharma SK; Bhatt RM; Sharma VP
    Indian J Malariol; 1996 Dec; 33(4):173-9. PubMed ID: 9125831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.
    Llanos-Cuentas A; Lacerda MV; Rueangweerayut R; Krudsood S; Gupta SK; Kochar SK; Arthur P; Chuenchom N; Möhrle JJ; Duparc S; Ugwuegbulam C; Kleim JP; Carter N; Green JA; Kellam L
    Lancet; 2014 Mar; 383(9922):1049-58. PubMed ID: 24360369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of three chloroquine-primaquine regimens for treatment of Plasmodium vivax malaria in Colombia.
    Alvarez G; Piñeros JG; Tobón A; Ríos A; Maestre A; Blair S; Carmona-Fonseca J
    Am J Trop Med Hyg; 2006 Oct; 75(4):605-9. PubMed ID: 17038680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.